(Q35468992)

8 August 2017

title

Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity (English)

1 reference

Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant

8 August 2017

main subject

0 references

hyperparathyroidism

1 reference

primary hyperparathyroidism

inferred from title

1 reference

8

Dolores Shoback

1 reference

8 August 2017

Munro Peacock

1

1 reference

8 August 2017

J P Bilezikian

2

1 reference

8 August 2017

M A Bolognese

3

1 reference

8 August 2017

Michael Borofsky

4

1 reference

8 August 2017

Simona Scumpia

5

1 reference

8 August 2017

L R Sterling

6

1 reference

8 August 2017

Sunfa Cheng

7

1 reference

8 August 2017

language of work or name

English

0 references

publication date

13 October 2010

1 reference

The Journal of Clinical Endocrinology and Metabolism

8 August 2017

published in

1 reference

8 August 2017

volume

96

1 reference

8 August 2017

issue

1

1 reference

8 August 2017

page(s)

E9-18

1 reference

Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD.

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Expression and signal transduction of calcium-sensing receptors in cartilage and bone

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Dietary phosphate and parathyroid hormone alter the expression of the calcium-sensing receptor (CaR) and the Na+-dependent Pi transporter (NaPi-2) in the rat proximal tubule.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203649

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

26 September 2018

1 reference

12 December 2020

Calcium-sensing receptor and renal cation handling

1 reference

12 December 2020

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial

1 reference

12 December 2020

Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century

1 reference

12 December 2020

Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism

1 reference

12 December 2020

Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure

1 reference

12 December 2020

Calcimimetic Compounds: a Direct Approach to Controlling Plasma Levels of Parathyroid Hormone in Hyperparathyroidism

1 reference

12 December 2020

Identifiers

DOI

10.1210/JC.2010-1221

1 reference

8 August 2017

1 reference

8 August 2017

1 reference